Medical Foods Market to Reach USD 29.54 Billion by 2026, at a CAGR of 6.9% | Danone, Primus Pharmaceuticals, Inc., Abbott, etc.

Based on current analysis the global medical foods market was valued at USD 17.27 billion in 2018 and is expected to reach USD 29.54 billion by 2026, at a CAGR 6.9% Medical foods are planned for specific dietary management of a disease or a condition for which distinctive nutritional requirements, based on recognized scientific principles are established by medical evaluation. It is mandatory to consume medical foods under the supervision of a physician.

Companies profiled for this market study

Protruding players operating in the market include Danone, Primus Pharmaceuticals, Inc., Nestl, Abbott, Meiji Holdings and Co., Targeted Medical Pharma, Inc., Mead Johnson & Company, LLC., Accera, Inc., and Alfasigma

Get a Sample Copy of this Report before you purchase free of cost @ https://www.reportsanddata.com/sample-enquiry-form/1491

Type (Revenue in USD Million; 2016-2026)
o Pills and tablets
o Powder
o Others

Applications (Revenue in USD Million; 2016-2026)
o Chronic kidney disease
o Minimal hepatic encephalopathy
o Chemotherapy-induced diarrhea
o Pathogen-related infections
o Diabetic neuropathy
o ADHD
o Depression
o Alzheimer's disease
o Nutritional deficiency
o Orphan diseases
o Phenylketonuria
o Eosinophilic esophagitis
o FPIES
o Others
o Other

Route of Administration (Revenue in USD Million; 2016-2026)
o Oral
o Enteral

Sales Channel (Revenue in USD Million; 2016-2026)
o Online Sales
o Institutional Sales
o Retail Sales

Regional Outlook (Revenue in USD Million; 2016-2026)
o North America (United States, Canada and Mexico)
o Europe (Germany, France, UK, Russia and Italy)
o Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
o South America (Brazil, Argentina, Colombia)

Click here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/1491

Medical foods are to be consumed or administered enterally. Specially formulated and intended for the dietary management of a disease that has distinctive nutritional needs that cannot be met by normal diet alone are known to be medical foods. Medical foods are not required to undergo premarket review or approval by FDA. Besides, they are relieved from the labeling requirements for health claims and nutrient content claims under the Nutrition Labeling and Education Act of 1990. Medical foods are customized for both pediatric and adult use and are available in a variety of forms, including powders, liquids, capsules, tablets, and bars. Moreover, they are specialized blends of macronutrients, vitamins, minerals, phytochemicals, and botanicals or preparations composed of a single nutrient.

The rising elderly population is a major driver for the global medical foods market. They are more likely to advance nutritional disorders as well as to fall prey to other diseases that affect their capacity to absorb nutrients from their diet. Nutrition deficiency disorders are also more common among the geriatric demographic than in other patient classes, leading to the elderly population becoming a key consumer sector for the global medical foods market. The increasing prevalence of diabetes across the world is another key driver for the global medical foods market.

Moreover, technological progressions have abridged the cost of enteral drug administration, making it profitable. North America is expected to dominate the market with a market share of xx% during the forecast period.

Key findings from the report

o Due to high disease prevalence, diabetic neuropathy held the largest market share of 51.1% in 2018. Also, chronic kidney disorder is expected to emerge with the fastest CAGR of 6.6%

o In the United States, Alzheimer is the 6th leading cause of death. An estimated 5.8 million Americans of all ages are living with Alzheimer's dementia in 2019. This number includes an estimated 5.6 million people age 65 and older and roughly 200,000 individuals under age 65 who have younger-onset Alzheimer's

o Worldwide, 300 million people of all ages are suffering from depression. Depression is termed to be leading cause of disability around the world and is a key contributor to the overall global burden of disease

o VAYA Pharma, Inc. introduced Vayarin Plus, extending its medical food offerings. The extra-strength formula in Vayarin, is indicated for the clinical dietary management of ADHD in adolescents and adults weighing over 97 lbs. Constant innovations and new product launches by leading manufacturers are the major factors boosting the demand for medical foods market...Continued

Read the Comprehensive Report with a meticulous TOC and panoramic coverage of the market @ https://www.reportsanddata.com/report-detail/medical-foods-market

In conclusion, the Medical Foods Market report is a reliable source for accessing the Market data that will exponentially accelerate your business. The report provides the principal locale, economic scenarios with the item value, benefit, supply, limit, generation, request, Market development rate, and figure and so on. Besides, the report presents a new task SWOT analysis, speculation attainability investigation, and venture return investigation.

Contact Us:

John Watson
Head of Business Development
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.